Implication de la Lipocaline 2 dans les effets physiopathologiques du récepteur minéralocorticoïde dans le système cardiovasculaire.

Implication de la Lipocaline 2 dans les effets physiopathologiques du récepteur minéralocorticoïde dans le système cardiovasculaire.

Les pathologies cardiovasculaires sont la première cause de mortalité dans le monde. Parmi les mécanismes participant à ces pathologies figurent l'activation de la voie de signalisation minéralocorticoïde. Notre laboratoire a précédemment identifié la Lipocaline 2 (Lcn2) comme cible directe du...

Full description

Bibliographic Details
Main Author:	Tarjus, Antoine
Other Authors:	Paris 6
Language:	fr
Published:	2014
Subjects:	Lipocaline 2 Aldostérone Récepteur minéralocorticoïde Fibrose Inflammation Cardiovasculaire Cardiovascular Mineralocorticoid receptor 612
Online Access:	http://www.theses.fr/2014PA066457/document

Similar Items

Les cibles moléculaires du récepteur minéralocorticoïde dans le coeur
by: Gravez, Basile
Published: (2015)

Identification et régulation transcriptionnelle des gènes cibles du récepteur des minéralocorticoïdes dans les cellules rénales
by: Le Billan, Florian
Published: (2017)

Mineralocorticoid receptors in the pathophysiology of vascular inflammation and atherosclerosis.
by: Mary Elizabeth Moss, et al.
Published: (2015-09-01)

Prévention de l'insuffisance cardiaque par l'antagonisation du récepteur des minéralocorticoïdes dans un contexte de syndrome métabolique : une étude intégrative du phénome, du transcriptiome et du miRNOme
by: Youcef, Gina
Published: (2014)

Contrôle post-transcriptionnel de l'expression rénale du récepteur minéralocorticoide par les variations de tonicité extracellulaire : conséquences physiopathologiques.
by: Lema, Ingrid
Published: (2016)

Mineralocorticoid Receptor-Dependent Impairment of Baroreflex Contributes to Hypertension in a Mouse Model of Primary Aldosteronism
by: Luo Shi, et al.
Published: (2019-11-01)

MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
by: V. N. Soboleva, et al.
Published: (2015-01-01)

Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses
by: Fernet M, et al.
Published: (2018-09-01)

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
by: Greg H. Tesch, et al.
Published: (2017-05-01)

Mineralocorticoid receptor antagonist use after hospitalization of patients with heart failure and post-discharge outcomes: a single-center retrospective cohort study
by: Matthew S. Durstenfeld, et al.
Published: (2019-08-01)

Rôle de la Neutrophil Gelatinase-Associated Lipocalin dans les effets cardiovasculaires et rénaux de l'activation du récepteur minéralocorticoïde. Spécificité et mécanismes d’action
by: Buonafine, Mathieu
Published: (2017)

Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity?
by: Line Aas Mortensen, et al.
Published: (2017-11-01)

Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015
by: Yu F Osmolovskaya, et al.
Published: (2015-09-01)

The Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor
by: Rene Baudrand, et al.
Published: (2018-02-01)

Mineralocorticoid receptor antagonists in the treatment of patients with heart failure after myocardial infarction and those with chronic heart failure
by: S N Tereshchenko, et al.
Published: (2013-12-01)

Impact du récepteur minéralocorticoïde sur le métabolisme énergétique
by: Kuhn, Emmanuelle
Published: (2014)

Mineralocorticoid hypertension
by: Vishal Gupta
Published: (2011-01-01)

Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice
by: Marie Pieronne‐Deperrois, et al.
Published: (2021-06-01)

Specific activation of the alternative cardiac promoter of Cacna1c by the mineralocorticoid receptor
by: Ribeiro mesquita, Thássio Ricardo
Published: (2017)

Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
by: Yuta Tezuka, et al.
Published: (2021-03-01)

Eight weeks of mineralocorticoid blockade does not improve insulin sensitivity in type 2 diabetes
by: Stine H. Finsen, et al.
Published: (2021-08-01)

Aldosterone Inhibits In Vitro Myogenesis by Increasing Intracellular Oxidative Stress via Mineralocorticoid Receptor
by: Jin Young Lee, et al.
Published: (2021-08-01)

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists
by: Yugar-Toledo JC, et al.
Published: (2017-10-01)

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial
by: Tomaschitz Andreas, et al.
Published: (2012-09-01)

Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease
by: Stefania Gorini, et al.
Published: (2018-09-01)

Le rôle de l’aldostérone sur le remodelage structurel pulmonaire et la fonction ventriculaire droite en insuffisance cardiaque congestive
by: Chabot, Andréanne
Published: (2012)

Le rôle de l’aldostérone sur le remodelage structurel pulmonaire et la fonction ventriculaire droite en insuffisance cardiaque congestive
by: Chabot, Andréanne
Published: (2012)

Mineralocorticoid Receptor Antagonists
by: Ilaria Spoletini, et al.
Published: (2019-01-01)

The tubulogenic effect of aldosterone is attributed to intact binding and intracellular response of the mineralocorticoid receptor
by: Minuth Will, et al.
Published: (2007-09-01)

Comentario. Mineralocorticoides: Una vida para su investigación.
by: Alfredo Jácome Roca
Published: (2001-08-01)

Effects of chronically high levels of aldosterone on different cognitive dimensions: an investigation in patients with primary aldosteronism
by: Lukas Engler, et al.
Published: (2019-04-01)

PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy
by: Stephen eOrena, et al.
Published: (2013-10-01)

Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection
by: A. M. Esayan, et al.
Published: (2018-04-01)

Cardiac Mineralocorticoid Receptor and the Na+/H+ Exchanger: Spilling the Beans
by: Irene Lucía Ennis, et al.
Published: (2021-01-01)

Rol inmunomodulador de la activación del receptor mineralocorticoides por corticosterona
by: Letelier Torres, Nicole Alejandra
Published: (2016)

Mineralocorticoid Receptor Signaling Contributes to Normal Muscle Repair After Acute Injury
by: J. Spencer Hauck, et al.
Published: (2019-10-01)

Rôle du cortisol dans le développement des ionocytes de la peau chez l'embryon de médaka (Oryzias Latipes) et conséquences sur l'osmorégulation des stades larvaires
by: Trayer, Vincent
Published: (2013)

Regulación de la acción de la Aldosterona al nivel del receptor mineralocorticoide
by: Roberto Franco Saenz
Published: (2001-08-01)

Posttranslational Modifications of the Mineralocorticoid Receptor and Cardiovascular Aging
by: Yekatarina Gadasheva, et al.
Published: (2021-05-01)

Glucocorticoids Activate Cardiac Mineralocorticoid Receptors in Adrenalectomized Dahl Salt- Sensitive Rats
by: NAGATA, KOHZO, et al.
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7tmt43gpfbgmm5434obucuc722